DEL PRETE, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 2.637
EU - Europa 1.074
AS - Asia 944
SA - Sud America 294
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 76
Totale 5.111
Nazione #
US - Stati Uniti d'America 2.563
SG - Singapore 295
BR - Brasile 239
IT - Italia 206
VN - Vietnam 192
CN - Cina 182
RU - Federazione Russa 164
UA - Ucraina 146
DE - Germania 107
SE - Svezia 97
TR - Turchia 90
IE - Irlanda 73
FI - Finlandia 66
FR - Francia 58
DK - Danimarca 56
HK - Hong Kong 48
GB - Regno Unito 43
CA - Canada 39
CI - Costa d'Avorio 32
KR - Corea 31
IN - India 27
MA - Marocco 25
AR - Argentina 17
NL - Olanda 17
BD - Bangladesh 16
JP - Giappone 16
CO - Colombia 12
MX - Messico 12
ZA - Sudafrica 10
EC - Ecuador 9
ES - Italia 8
ID - Indonesia 8
IQ - Iraq 8
BE - Belgio 7
DZ - Algeria 6
IL - Israele 6
PL - Polonia 6
CL - Cile 5
CZ - Repubblica Ceca 5
GT - Guatemala 5
MY - Malesia 5
VE - Venezuela 5
CR - Costa Rica 4
HN - Honduras 4
UY - Uruguay 4
KE - Kenya 3
RS - Serbia 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AO - Angola 2
AT - Austria 2
AZ - Azerbaigian 2
CW - ???statistics.table.value.countryCode.CW??? 2
EG - Egitto 2
JM - Giamaica 2
KZ - Kazakistan 2
LT - Lituania 2
PK - Pakistan 2
PR - Porto Rico 2
PY - Paraguay 2
SA - Arabia Saudita 2
TW - Taiwan 2
AL - Albania 1
BB - Barbados 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
LB - Libano 1
MD - Moldavia 1
MR - Mauritania 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
SV - El Salvador 1
Totale 5.038
Città #
Ashburn 462
Chandler 194
Singapore 184
Jacksonville 152
Fairfield 150
San Jose 126
Dallas 103
New York 93
Council Bluffs 88
Wilmington 87
Boardman 81
Dublin 73
Seattle 68
Woodbridge 65
Ann Arbor 64
Ho Chi Minh City 59
Houston 53
Beijing 50
Centro 49
Hanoi 47
Los Angeles 45
Hong Kong 44
Princeton 38
Moscow 36
The Dalles 36
Cambridge 34
Turin 34
Munich 32
Abidjan 31
Lawrence 31
San Mateo 31
Lauterbourg 27
Turku 22
Des Moines 20
Orem 18
Santa Clara 17
São Paulo 17
Helsinki 16
London 15
Montreal 15
San Diego 15
Buffalo 14
Tokyo 14
Hefei 13
Milan 13
Atlanta 12
Chennai 10
Rio de Janeiro 10
Chicago 9
Amsterdam 8
Denver 8
Frankfurt am Main 8
Porto Alegre 8
Pune 8
Stockholm 8
Columbus 7
Thái Nguyên 7
Brussels 6
Da Nang 6
Fortaleza 6
Izmir 6
Johannesburg 6
Manchester 6
Phoenix 6
Poplar 6
Warsaw 6
Biên Hòa 5
Bến Tre 5
Charlotte 5
Curitiba 5
Olomouc 5
Paris 5
Shanghai 5
Toronto 5
Wuhan 5
Belo Horizonte 4
Bogotá 4
Brooklyn 4
Campinas 4
Goiânia 4
Guangzhou 4
Guatemala City 4
Guayaquil 4
Haiphong 4
Montevideo 4
Quảng Ngãi 4
Rome 4
Salt Lake City 4
San Francisco 4
San José 4
St Petersburg 4
Washington 4
Abbeville 3
Boston 3
Brasília 3
Bắc Giang 3
Can Tho 3
Casablanca 3
Caxias do Sul 3
City of London 3
Totale 3.170
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 228
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment 207
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 205
A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay 205
Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: A multicentric retrospective analysis 203
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 201
Optimal management of resected gastric cancer 194
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 180
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 174
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 170
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab 169
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 163
Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: Are all mutations equal? 163
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 163
Panitumumab for the treatment of metastatic colorectal cancer: A review 157
Trattamento del carcinoma del pancreas. Attualità e prospettive 154
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 152
Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients 147
Novel perspectives for the treatment of gastric cancer: From a global approach to a personalized strategy 146
The "angiogenetic ladder", step-wise angiogenesis inhibition in metastatic colorectal cancer 144
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 143
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 143
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 143
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer 142
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 140
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 139
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 136
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 134
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 124
Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey 123
Gastric cancer: Therapeutic choices in advanced disease 117
The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy 102
Totale 5.111
Categoria #
all - tutte 22.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.157


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022168 0 0 0 0 2 18 13 18 12 39 18 48
2022/2023560 40 76 45 43 36 74 1 35 130 6 63 11
2023/2024317 48 6 28 38 33 104 4 5 1 6 2 42
2024/2025672 99 56 12 14 39 32 79 28 107 49 86 71
2025/20261.845 131 191 120 206 238 124 289 179 124 147 27 69
2026/2027317 58 44 57 152 6 0 0 0 0 0 0 0
Totale 5.111